Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Real-time Opioid Study

NCT: NCT07768007 · NOT_YET_RECRUITING

NCT IDNCT07768007
StatusNOT_YET_RECRUITING
Start Date2026-08
Completion2027-02
SponsorYale University (OTHER)
First posted
Last updated

Brief Summary

This feasibility study collects initial data on the use of an fMRI neurofeedback protocol for treating anhedonia in methadone-treated individuals with opioid use disorder (OUD). The intervention tested has previously been shown to reduce anhedonia in individuals with depression and this study is collecting first-in-human data in an OUD population. Investigators will assess tolerability of the intervention and collect preliminary data from 2-3 subjects monitoring changes in anhedonia, non-substance-related autobiographical memory recall, and meaning in life.

Frequently Asked Questions

What is Real-time Opioid Study?

Real-time Opioid Study is a clinical trial registered under NCT07768007. Current status: NOT_YET_RECRUITING.

What is the status of NCT07768007?

The current status of NCT07768007 (Real-time Opioid Study) is: NOT_YET_RECRUITING.

When did Real-time Opioid Study start?

Real-time Opioid Study started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.